Immunocore Holdings (IMCR)

Immunocore Holdings (IMCR) Cash flow


Immunocore Holdings Cash Flow

IMCR's free cash flow for Q4 2022 was £4.70M. For the 2022 fiscal year, IMCR's free cash flow was decreased by £68.96M and operating cash flow was £6.03M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
£ -25.89M£ -25.89M£ -96.11M£ -61.25M£ -101.38M£ -16.63M
Investing Cash Flow
£ 193.00K£ 193.00K£ -367.00K£ 1.14M£ -4.14M£ 58.01M
Financing Cash Flow
£ 114.45M£ 114.45M£ 204.63M£ 115.94M£ 55.13M£ 101.00K
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
£ 1.09B£ 332.54M£ 237.89M£ 129.72M£ 73.97M£ 124.39M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
£ 116.81M£ 116.81M£ 226.53M£ 83.22M£ 59.87M£ 0.00
Issuance Of Debt
-£ -46.72M£ -3.16M£ 37.54M£ 0.00£ 0.00
Repayment Of Debt
£ -46.72M£ -46.72M£ -3.16M£ -4.43M£ -4.04M£ 0.00
Free Cash Flow
£ -28.09M£ -28.08M£ -97.04M£ -64.32M£ -105.65M£ -20.16M
Domestic Sales
Foreign Sales
Currency in GBP

Immunocore Holdings Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis